Lexeo Therapeutics filed for an IPO on Friday. The company develops genetic medicines, with candidates for treatment of Friedreich’s ataxia and Alzheimer’s currently being...
Friday, September 29th, 2023 – yPredict is the first all-in-one ecosystem for traders, bringing together AI-generated trading signals and technical analysis, quantitative analysis, real-time...
The Schwab Fundamental Emerging Markets Large Company ETF (NYSEARCA:FNDE) invests across international stocks from developing economies. The attraction here is an expectation for higher...
Biogen Inc. BIIB, -0.32% said late Friday the Food and Drug Administration approved its biosimilar version of Roche ROG, +0.30% ‘s arthritis treatment Actemra....